Introduction: The new coronavirus constitutes a public health problem due to its many often fatal complications such as thromboembolic diseases. Upper this infectious state, neurological diseases are reported mainly ischemic stroke and rarely cerebral venous thrombosis. Observation: We report the case of a 76-year-old diabetic, hypertensive patient who was well monitored and who presented neurological manifestations 24 hours after home returning from hospitalization for COVID 19 infection fifteen days before. Major signs were dehydration grade I according to the WHO, confusional syndrom, left pyramidal syndrom of cortical type predominantly on facial and arm and regular tachycardia. The brain imagery revealed a double thrombus in sinus and diagnosis of cerebral thrombosis (CVT) was made. Biological abnormalities were noted, such as neutrophilic hyperleukocytosis and thrombocytopenia. The evolution was favorable with symptomatic treatment and after putting on oral curative dosis anticoagulant. Conclusion: Cases of cerebral venous thrombosis are increasingly reported in the literature, but Cases of CVT in the field COVID 19 remain rare, especially in Africa. Elderly age and vascular risk factors could favorite occurrence of cerebral venous thrombosis in cases of Sars-Cov infection. It is important to think about it in the face of any brain neurological picture given the thrombogenic nature of COVID 19, mainly in geriatric population. However, guidelines must been done for better management of these patients even if outcomes evolution are generally favourable.
Published in | Clinical Neurology and Neuroscience (Volume 8, Issue 1) |
DOI | 10.11648/j.cnn.20240801.12 |
Page(s) | 8-11 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Cerebral Venous Thrombosis, New Coronavirus, Anticoagulant, Neurology, CHU Fann, Dakar, Senegal
[1] | Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, et al. Neuropathological features of COVID-19. N Engl J Med 2020; 0 [null]. |
[2] | Maatman TK, Jalali F, Feizpour C, Douglas 2nd A, McGuire SP, Kinnaman G, et al. Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med 2020. |
[3] | Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9-14. |
[4] | Bouguila Hajer, Ghachem Ichrak, Ameny Ameur, Brahim Syrine, Samia Younes. Les manifestations neurologiques de la pandémie COVID-19. Revue neurologique 2022; 178: S2-S139. |
[5] | Khan IH, Savarimuthu S, Tsun Leung MS, Harky A. The need to manage the risk of thromboembolism in COVID-19 patients. J Vasc Surg. 2020; 5. https://doi.org/10.1016/j. jvs.2020.05.015. |
[6] | Tian Ming Tu, Claire Goh, Ying Kiat Tan. Cerebral Venous Thrombosis in Patients with COVID-19 Infection: A Case Series and Systematic Review. Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 12 (December), 2020: 105379. |
[7] | Flis-Richard H., Verdonk F. Atteintes neurologiques dans l’infection du SARS-CoV-2 (COVID-19). Le Praticien en anesthésie réanimation (2020) 24, 186-189 |
[8] | Katarina Dakay DO, Jared Cooper, Jessica Bloomfield. Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The Literature; Journal of Stroke and Cerebrovascular Diseases, Vol. 30, No. 1 (January), 2021: 105434. |
[9] | Li Y, Wang M, Zhou Y. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. SSRN Electron J 2020. |
[10] | Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683—90, http://dx.doi.org/10.1001/jamaneurol.2020.1127. |
[11] | Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 2020; 0, http://dx.doi.org/10.1016/S2215-0366(20)30287-X. |
[12] | Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382: 2268-70. |
[13] | Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S. Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med 2020; 7 (5): 001691. |
[14] | Ferro JM, Bousser MG, Canhao P, et al. European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European academy of neurology. Eur Stroke J 2017; 2: 195-221. |
[15] | Costa A, Weinstein ES, Sahoo DR, et al. How to build the plane while flying: VTE/PE thromboprophylaxis clinical guidelines for COVID-19 patients. Disaster Med Public Health Prep 2020; 1-15. |
[16] | Ghosh R., Roy D., Mandal A. et al. Cerebral venous thrombosis in COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2021; 15: 1039-1045. |
[17] | Khattab H., Sikkal A., Bellakhdar S. et al. Neuro-COVID-19 et population gériatrique: quelles particularités? NPG Neurologie - Psychiatrie - Gériatrie 2022; 22: 158-166. |
APA Style
Sow, A. D., Basse, A. M., Mansoj, H. M., Fall, A. A., Gaye, N. M., et al. (2024). Cerebral Venous Thrombosis Post COVID 19 in Neurological Unit of Fann Teaching Hospital, Dakar – Senegal. Clinical Neurology and Neuroscience, 8(1), 8-11. https://doi.org/10.11648/j.cnn.20240801.12
ACS Style
Sow, A. D.; Basse, A. M.; Mansoj, H. M.; Fall, A. A.; Gaye, N. M., et al. Cerebral Venous Thrombosis Post COVID 19 in Neurological Unit of Fann Teaching Hospital, Dakar – Senegal. Clin. Neurol. Neurosci. 2024, 8(1), 8-11. doi: 10.11648/j.cnn.20240801.12
AMA Style
Sow AD, Basse AM, Mansoj HM, Fall AA, Gaye NM, et al. Cerebral Venous Thrombosis Post COVID 19 in Neurological Unit of Fann Teaching Hospital, Dakar – Senegal. Clin Neurol Neurosci. 2024;8(1):8-11. doi: 10.11648/j.cnn.20240801.12
@article{10.11648/j.cnn.20240801.12, author = {Adjaratou Dieynabou Sow and Anna Modji Basse and Halladain Mpung Mansoj and Abdou Aziz Fall and Ndiaga Matar Gaye and Marième Soda Diop and Maouly Fall and Ngor Side Diagne and Lala Bouna Seck and Kamadore Touré and Moustapha Ndiaye and Amadou Gallo Diop}, title = {Cerebral Venous Thrombosis Post COVID 19 in Neurological Unit of Fann Teaching Hospital, Dakar – Senegal}, journal = {Clinical Neurology and Neuroscience}, volume = {8}, number = {1}, pages = {8-11}, doi = {10.11648/j.cnn.20240801.12}, url = {https://doi.org/10.11648/j.cnn.20240801.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cnn.20240801.12}, abstract = {Introduction: The new coronavirus constitutes a public health problem due to its many often fatal complications such as thromboembolic diseases. Upper this infectious state, neurological diseases are reported mainly ischemic stroke and rarely cerebral venous thrombosis. Observation: We report the case of a 76-year-old diabetic, hypertensive patient who was well monitored and who presented neurological manifestations 24 hours after home returning from hospitalization for COVID 19 infection fifteen days before. Major signs were dehydration grade I according to the WHO, confusional syndrom, left pyramidal syndrom of cortical type predominantly on facial and arm and regular tachycardia. The brain imagery revealed a double thrombus in sinus and diagnosis of cerebral thrombosis (CVT) was made. Biological abnormalities were noted, such as neutrophilic hyperleukocytosis and thrombocytopenia. The evolution was favorable with symptomatic treatment and after putting on oral curative dosis anticoagulant. Conclusion: Cases of cerebral venous thrombosis are increasingly reported in the literature, but Cases of CVT in the field COVID 19 remain rare, especially in Africa. Elderly age and vascular risk factors could favorite occurrence of cerebral venous thrombosis in cases of Sars-Cov infection. It is important to think about it in the face of any brain neurological picture given the thrombogenic nature of COVID 19, mainly in geriatric population. However, guidelines must been done for better management of these patients even if outcomes evolution are generally favourable. }, year = {2024} }
TY - JOUR T1 - Cerebral Venous Thrombosis Post COVID 19 in Neurological Unit of Fann Teaching Hospital, Dakar – Senegal AU - Adjaratou Dieynabou Sow AU - Anna Modji Basse AU - Halladain Mpung Mansoj AU - Abdou Aziz Fall AU - Ndiaga Matar Gaye AU - Marième Soda Diop AU - Maouly Fall AU - Ngor Side Diagne AU - Lala Bouna Seck AU - Kamadore Touré AU - Moustapha Ndiaye AU - Amadou Gallo Diop Y1 - 2024/01/11 PY - 2024 N1 - https://doi.org/10.11648/j.cnn.20240801.12 DO - 10.11648/j.cnn.20240801.12 T2 - Clinical Neurology and Neuroscience JF - Clinical Neurology and Neuroscience JO - Clinical Neurology and Neuroscience SP - 8 EP - 11 PB - Science Publishing Group SN - 2578-8930 UR - https://doi.org/10.11648/j.cnn.20240801.12 AB - Introduction: The new coronavirus constitutes a public health problem due to its many often fatal complications such as thromboembolic diseases. Upper this infectious state, neurological diseases are reported mainly ischemic stroke and rarely cerebral venous thrombosis. Observation: We report the case of a 76-year-old diabetic, hypertensive patient who was well monitored and who presented neurological manifestations 24 hours after home returning from hospitalization for COVID 19 infection fifteen days before. Major signs were dehydration grade I according to the WHO, confusional syndrom, left pyramidal syndrom of cortical type predominantly on facial and arm and regular tachycardia. The brain imagery revealed a double thrombus in sinus and diagnosis of cerebral thrombosis (CVT) was made. Biological abnormalities were noted, such as neutrophilic hyperleukocytosis and thrombocytopenia. The evolution was favorable with symptomatic treatment and after putting on oral curative dosis anticoagulant. Conclusion: Cases of cerebral venous thrombosis are increasingly reported in the literature, but Cases of CVT in the field COVID 19 remain rare, especially in Africa. Elderly age and vascular risk factors could favorite occurrence of cerebral venous thrombosis in cases of Sars-Cov infection. It is important to think about it in the face of any brain neurological picture given the thrombogenic nature of COVID 19, mainly in geriatric population. However, guidelines must been done for better management of these patients even if outcomes evolution are generally favourable. VL - 8 IS - 1 ER -